ABROCITINIB vs ACAMPROSATE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ABROCITINIB vs ACAMPROSATE: Safety Overview
| Metric | ABROCITINIB | ACAMPROSATE |
|---|---|---|
| Total FAERS Reports | 3,170 | 524 |
| Deaths Reported | 57 | 53 |
| Death Rate | 1.8% | 10.1% |
| Hospitalizations | 329 | 290 |
| Average Patient Age | 48.5 yrs | 51.7 yrs |
| % Female Patients | 53.9% | 36.9% |
| FDA Approval Date | Jan 14, 2022 | Jul 16, 2013 |
| Manufacturer | U.S. Pharmaceuticals | American Health Packaging |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Discontinued |